Marco Metra(@MarcoMetra) 's Twitter Profileg
Marco Metra

@MarcoMetra

ID:1210168681

calendar_today23-02-2013 00:21:54

602 Tweets

1,7K Followers

96 Following

Follow People
Gregg Fonarow MD(@gcfmd) 's Twitter Profile Photo

What do you predict for age-adjusted HF-related mortality in 2022, 2023, and 2024?

Reversals in the Decline of Heart Failure Mortality in the US, 1999 to 2021 jamanetwork.com/journals/jamac…

JAMA Cardiology JAMA

account_circle
C. Michael Gibson MD(@CMichaelGibson) 's Twitter Profile Photo

I’m proud to announce Dr. Jim Januzzi’s promotion to Chief Scientific Officer Baim Institute (formerly Harvard Clinical Research Institute or HCRI). BaimInstitute.org

Dr. Januzzi is a brilliant clinical researcher and an academic superstar. His groundbreaking work in the…

I’m proud to announce Dr. Jim Januzzi’s promotion to Chief Scientific Officer @BaimInstitute (formerly Harvard Clinical Research Institute or HCRI). BaimInstitute.org Dr. Januzzi is a brilliant clinical researcher and an academic superstar. His groundbreaking work in the…
account_circle
Muthu Vaduganathan(@mvaduganathan) 's Twitter Profile Photo

. , one of the most highly anticipated trials of yr, to be presented

Sema 1.0mg once weekly *disease modifying* in CKD+T2D
✅ ↓ Composite kidney events
✅ Slower eGFR decline
✅ ↓ MACE
✅ ↓ All-cause mortality

A new era, firmly establishes 4th pillar in !

.#FLOW, one of the most highly anticipated #CKM trials of yr, to be presented #ERA24 Sema 1.0mg once weekly *disease modifying* in CKD+T2D ✅ ↓ Composite kidney events ✅ Slower eGFR decline ✅ ↓ MACE ✅ ↓ All-cause mortality A new era, firmly establishes 4th pillar in #CKD!
account_circle
Gregg Fonarow MD(@gcfmd) 's Twitter Profile Photo

How have HF mortality rates changed from 1999-2021 in the US?

From 1999-2012
↘ : Decline by ~25%

From 2012-2021
↗ Reversals that have now undone ALL initial declines.

🚨HF mortality in 2021 > HF mortality in 1999 🚨

jamanetwork.com/journals/jamac…

Marat Fudim, MD MHS Ahmed Sayed HFSA

account_circle
Christopher O'Connor(@coconnormd) 's Twitter Profile Photo

It was a privilege to present Norman Stockbridge with the 2024 HFC Lifetime Achievement Award for contributions to regulatory science, advocacy for the community without walls,and his disciplined integrity that has improved many pts. via CV and renal therapies.⁦Robert Harrington

It was a privilege to present Norman Stockbridge with the 2024 HFC Lifetime Achievement Award for contributions to regulatory science, advocacy for the community without walls,and his disciplined integrity that has improved many pts. via CV and renal therapies.⁦@HeartBobH⁩
account_circle
European Society of Cardiology(@escardio) 's Twitter Profile Photo

How can the work towards finding the sweetspot between ensuring safety and efficacy of a new medical device, and ensuring innovation breakthroughs have a quick regulatory pathway, so that we ultimately maintain patient welfare as our top priority? Stephan Windecker…

account_circle
HFAPresident(@HFA_President) 's Twitter Profile Photo

📣📣 HFA Elections: voting now open ! 📣📣

Let me express my warmest thanks to all candidates! Their large participation testifies HFA vitality and appeal.

Discover the candidates: bit.ly/3QaAGr8

All eligible voting members must participate: your vote will…

account_circle
Steve Greene(@SJGreene_md) 's Twitter Profile Photo

New data from now in European Society of Cardiology Journals

Across the spectrum of patient kidney function, no significant difference in clinical or patient-reported outcomes between torsemide and furosemide for treatment of HF.

Duke Clinical Research Institute Yale Cardiology

onlinelibrary.wiley.com/doi/full/10.10…

New data from #TRANSFORM_HF now in @ESC_Journals #EJHF Across the spectrum of patient kidney function, no significant difference in clinical or patient-reported outcomes between torsemide and furosemide for treatment of HF. @DCRINews @YaleCardiology onlinelibrary.wiley.com/doi/full/10.10…
account_circle
Marco Metra(@MarcoMetra) 's Twitter Profile Photo

Should All Translational Scientists Be Swifties? | JACC: Basic to Translational Science
jacc.org/doi/10.1016/j.…

Amazing Editorial! As outgoing Editor-in Chief of EJHF I felt threatened as well ! But the conclusions may be ... No spoilers, please, just read it all!

account_circle
Muthu Vaduganathan(@mvaduganathan) 's Twitter Profile Photo

New data in European Society of Cardiology Journals from & by Alexander Peikert

dapagliflozin shows consistent protection against hospitalizations & death in HF and prior MI

Will modify risk early after acute MI? Stay tuned for at !

onlinelibrary.wiley.com/doi/full/10.10…

New data in @ESC_Journals #EJHF from #DAPAHF & #DELIVER by @PeikertA #SGLT2i dapagliflozin shows consistent protection against hospitalizations & death in HF and prior MI Will #SGLT2i modify risk early after acute MI? Stay tuned for #EMPACTMI at #ACC24! onlinelibrary.wiley.com/doi/full/10.10…
account_circle
Journal of Cardiovascular Medicine(@JCardioMedicine) 's Twitter Profile Photo

👉ORIGINAL ARTICLES: CORONARY ARTERY DISEASE

🫀Prognostic role of coronary artery ectasia in patients with nonobstructive coronary artery disease

Link🖇️journals.lww.com/jcardiovascula…

account_circle
Henry Han(@HanCardiomd) 's Twitter Profile Photo

Medical therapy of shock: Contemporary use of and

The article discusses current evidence on the use of medications in patients with cardiogenic shock and discuss specific clinical settings with indications to their use.…

Medical therapy of #cardiogenic shock: Contemporary use of #inotropes and #vasopressors The article discusses current evidence on the use of medications in patients with cardiogenic shock and discuss specific clinical settings with indications to their use.…
account_circle
Steve Greene(@SJGreene_md) 's Twitter Profile Photo

Shockingly low rates of natriuretic peptide and echo testing in patients newly given a diagnosis of .

Improving timeliness and accuracy of diagnosis with appropriate testing remains a huge unmet need.

onlinelibrary.wiley.com/doi/full/10.10…

Shockingly low rates of natriuretic peptide and echo testing in patients newly given a diagnosis of #HF. Improving timeliness and accuracy of #HF diagnosis with appropriate testing remains a huge unmet need. onlinelibrary.wiley.com/doi/full/10.10…
account_circle